SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035165
Filing Date
2024-08-06
Accepted
2024-08-06 16:02:42
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20240630.htm   iXBRL 10-Q 1071071
2 EX-31.1 sgmo-20240630xex311.htm EX-31.1 10020
3 EX-31.2 sgmo-20240630xex312.htm EX-31.2 10135
4 EX-32.1 sgmo-20240630xex321.htm EX-32.1 7131
  Complete submission text file 0001628280-24-035165.txt   5465100

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20240630.xsd EX-101.SCH 38354
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20240630_cal.xml EX-101.CAL 58228
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20240630_def.xml EX-101.DEF 193108
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20240630_lab.xml EX-101.LAB 435009
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20240630_pre.xml EX-101.PRE 318462
61 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20240630_htm.xml XML 707315
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 241179020
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)